Stevie Nicks and Lindsey Buckingham are on speaking terms again, having recently appeared on the 'Song Exploder' podcast, ...

They called Charles Barkley the "Round Mound of Rebound." Maybe not so round anymore after some very noticeable weight loss.

Join Joe Bart as he explores various gaming experiences and offers insights into philosophy while engaging with his community ...

The Purdue University Campaign Planning Committee hosted a pep rally Friday evening to celebrate the new “Victories and ...

diabetes treatments fuel Eli Lilly growth and spark bidding war In the recovery unit of UC San Diego Health, Salaysay helps patients manage pain after surgery. Along with medications, he offers tunes ...

Pharmaceutical maker Eli Lilly (LLY +1.13%) has seen its share price rocket higher by over 500% over the past five years.

Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

Eli Lilly ( LLY +1.06%) is part of this group. On Sept. 16, the drugmaker announced plans to build a $5 billion facility in Virginia. Here are two things investors should know.

Oct 6 (Reuters) - Eli Lilly (LLY.N), opens new tab will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, ...

Eli Lilly: Was I Too Cautious? We don't get everything right, do we? While I nailed the upgrade in Eli Lilly and Company (NYSE:LLY) stock in my last write-up in August, some of you might contend that ...

Eli Lilly and Company reported strong Phase 3 results for its oral GLP-1 drug orforglipron in type 2 diabetes, meeting all primary and secondary endpoints. LLY's GLP-1 franchise, including Mounjaro, ...